Pages

Sunday, March 22, 2015

जांघ के मांस से बना दिया महिला का स्तन

दिल्ली के डॉक्टरों ने चमत्कारिक काम करते हुए रविवार को एक 23 वर्षीय लड़की की जांघों का अतरिक्त मांस निकालकर प्रयोगशाला में प्राकृतिक स्तन का निर्माण कर दिया। गौरतलब है कि पोलैंड सिंड्रोम के एक आनुवांशिक विकार के चलते इस लड़की के बाएं स्तन का पूर्ण विकास नहीं हो पाया था। 

मध्यप्रदेश के इंदौर जिले की रहने वाली इस लड़की का इलाज दिल्ली के सर गंगाराम अस्पताल में किया गया। डॉक्टरों ने बताया कि लड़की इस विकार के चलते अवसाद में थी और हीनभावना से ग्रसित रहती थी। लेकिन इस लड़की ने हिम्मत नहीं हारी और इंटरनेट पर इसका समाधान खोजने की कोशिश की। डॉक्टरों ने बताया कि वह स्तन प्रत्यारोपड और ग्राफ्टिंग प्रक्रिया से भी गुजर सकती थी।

सर गंगा राम अस्पताल के प्लास्टिक और कॉस्मेटिक सर्जन विवेक कुमार से सलाह लेने के बाद इस लड़की ने फैट ग्राफ्टिंग प्रक्रिया से गुजरना उचित समझा क्योंकि उसने पाया कि यह प्रक्रिया प्राकृतिक है और यह बेहद आसानी सी सर्जरी है। 

कुमार ने बताया कि स्तन विकास के लिए यह आधुनिक तकनीक है और यह भारत में हाल ही में चर्चा में आई है। उन्होंने बताया कि स्तन की कॉस्मेटिक और पुनर्निर्माण संबंधी अन्य प्रक्रियाओं में भी इसका इस्तेमाल किया जाता है।

Thursday, March 19, 2015

IVF Nutrients May Influence Gender Selection In Embyros, But Is It Safe?

Chinese scientists believe that certain undisclosed nutrients given to embryos during in vitro fertilization may favor the development of male fetuses over female. The study is significant because it could possibly lead to a new technique for gender selection. However, experts are more concerned about what other changes that aren’t as obvious as sex these gender-specific nutrients may bring about.
During IVF a woman is stimulated to produce more eggs, which are then collected and fertilized outside of her body. For around five days fertilized embryos are grown in a petri dish, where lab technicians will then choose the healthiest looking embryos to reintroduce into the body for pregnancy.

Closely Guarded Nutrients

As reported in New Scientist, technicians working on IVF with cows found that the type of culture medium, or nutrients that embryos were grown in could influence how well male and female embryos develop. The 2001 study also revealed that a glucose-rich medium seemed to favor the development of male embryos and the loss of females in cows.
In order to test if the same remained true for human embryos, scientists at Peking University Third Hospital in China analyzed more than 4,400 IVF procedures during 2011 and 2013. The team took note of the type of culture medium used to grow each embryo. Although the specific components of the medium were kept confidential, the team revealed that in one medium the proportion of male births was 56 percent, while for another the proportion was just 45 percent. The uneven proportions remained even when the researchers took other factors into context, such as the parent’s age, body mass, and the type of infertility they were experiencing. Based on these findings, the team concluded that, like the bovine fetuses, human fetuses also varied in their response to different culture mediums depending on their gender.

Legalities

Gender selection is legal in the United States, but a 2014 survey given by the American Society for Reproductive Medicine revealed that only 21 percent of the American public actually agreed with the practice of choosing gender based only on sex preference with no medical underlying. Also known as gender selection or family balancing, certain techniques can nearly guarantee the birth of a certain sex. However, Slate reported that the American Society for Reproductive Medicine has expressed concern that otherwise healthy women are undergoing unnecessary medical treatments for the sole purpose of gender selection.
“It’s very commonly done,” Dr. David Adamson, a board certified reproductive endocrinologist and surgeon working for the Advanced Reproductive Care fertility clinic in California, told Medical Daily. “The decision that I made not to do that, personally, is not shared by the majority of doctors. I have partners that I respect a lot who will do it. It’s a difficult issue.”
New Scientist also reported that gender selection in IVF is illegal in Canada, the UK, and other Western countries, but this technique presented in the Chinese study could possibly present a loophole. Anti-gender bias laws rule that technicians are not allowed to select embryos based on their gender, but fertility clinics are free to use whichever medium to grow the embryos. That is, if the procedure works — something that experts are still very skeptical of.
“I don’t think it's effective enough to say that it’s a good therapeutic intervention,” Adamson said. “This may well be true, but in the absence of information about the culture medium, it’s difficult to interpret.”
Daniel Brison, a consultant embryologist at the University of Manchester in the UK seemed to agree with Adamson’s reasoning.
"A couple reading this paper who have already got a girl might well say 'hmm, perhaps I should be using the [male-favoring] medium,'" Brison told New Scientist. "But it's not really a very effective method of choosing a gender."

Is It Safe?

Other than the ineffectiveness of the procedure, Adamson raised a far more troubling concern: safety. The period immediately following fertilization is known to be genetically critical, but the culture medium also affects embryo growth. As a study from Maastricht University Medical Center in the Netherlands found last year, culture medium could affect birth weight in babies — a factor tied to lifelong health factors, such as a weak heart and diabetes, New Scientist reported. It’s unknown what other changes adjusting this medium to favor certain genders may result in.
Adamson explained that there is “zero evidence” that such a change would have no other impact other than gender on the embryo. His opinion mounts against many studies that suggest it may. Furthermore, testing necessary to document what effects manipulating the culture media would have on an embryo would be completely unethical.

Thursday, March 12, 2015

Limited Self-Renewal Of Stem Cells In The Brain

Stem cells in the brain can produce neurons and are consequently seen as a hope for treatment. A team of researchers from the Helmholtz Zentrum München and Ludwig-Maximilians-Universität München (LMU) has now discovered that the self-renewal rate of the stem cells is however limited, explaining why their number drops over the course of a lifetime. This work now sets the basis for further investigation of the signalling pathways that maintain the stem cells. The results have been published in the journalNature Neuroscience.

The generation of neurons (neurogenesis) in humans is predominantly limited to development; in the adult stage it takes place in only a few regions of the brain. These regions contain neural stem cells that generate neurons in a process with various intermediary stages.
Stem cell renewal is limited – total number drops
Until now it was thought that maintaining the stem cell pool was based on the self-renewal of individual stem cells. The team of scientists headed by Dr. Jovica Ninkovic and Professor Dr. Magdalena Götz were able to refute this: Both the self-renewal rate and the diversity of neurons formed from the stem cells are limited, and the number of stem cells decreases with age.
"Our findings explain why neurogenesis declines in later years, as there are fewer and fewer neural stem cells. At the same time, we gained new knowledge on basic mechanisms of neurogenesis that until now were not understood," says first author Dr. Filippo Calzolari.
Therapeutic approaches must focus on stem cells themselves
Approaches to new therapies for brain diseases, such as stroke or dementia, for example, particularly concentrate on replacing lost neurons by stimulating the generation of new cells from stem cells. "In light of the fact that the stem cell supply is limited, we must now also look for ways to promote the self-renewal rate of the stem cells themselves and maintain the supply for a longer time," emphasizes Götz, Director of the Institute for Stem Cell Research at the Helmholtz Zentrum München and Chair of the Institute of Physiological Genomics at LMU.